Consistent fusion of MOZ and TIF2 in AML with inv(8)(p11q13)

Cancer Genetics and Cytogenetics

Volumn 113, Issue 1, 1999, Pages 70-72

  Carapeti, Melina ^a   Aguiar, Ricardo C T ^b   Watmore, Ann E ^c   Goldman, John M ^a   Cross, Nicholas C P ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c Centre for Human Genetics   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CASE REPORT; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CYTOGENETICS; GENE FUSION; HUMAN; HUMAN CELL; KARYOTYPE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ACETYLTRANSFERASES; BLOTTING, SOUTHERN; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 8; HISTONE ACETYLTRANSFERASES; HUMANS; INVERSION, CHROMOSOME; KARYOTYPING; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; NUCLEAR RECEPTOR COACTIVATOR 2; TRANSCRIPTION FACTORS;

EID: 0032817504     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(99)00007-2     Document Type: Article

References (9)

1. Borrow J., Stanton V.P. Jr., Andresen J.M., Becher R., Behm F.G., Chaganti R.S.K., Civin C.I., Disteche C., Dubé I., Frischauf A.M., Horsman D., Mitelman F., Volinia S., Watmore A.E., Housman D.E. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nature Genet. 14:1996;33-41.
2. Aguiar R.C.T., Chase A., Coulthard S., Macdonald D.H.C., Carapeti M., Reiter A., Sohal J., Lennard A., Goldman J.M., Cross N.C.P. Abnormalities of chromosome band 8p11 in leukemia. two clinical syndromes can be distinguished on the basis of MOZ involvement Blood. 90:1997;3130-3135.
3. Carapeti M., Aguiar R.C.T., Goldman J.M., Cross N.C.P. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia. Blood. 91:1998;3127-3133.
4. Liang J., Prouty L., Williams B.J., Dayton M.A., Blanchard K.L. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in a fusion of the genes for MOZ and TIF2. Blood. 92:1998;2118-2122.
5. Coulthard S., Chase A., Orchard K., Watmore A., Vora A., Goldman J.M., Swirsky D.M. Two cases of inv(8)(p11q13) in AML with erythrophagocytosis; a new cytogenetic variant. Br J Haematol. 100:1998;561-563.
6. Giles R.H., Dauwerse J.G., Higgins C., Petrij F., Wessels J.W., Beverstock G.C., Dohner H., Jotterand-Bellomo M., Falkenburg J.H.F., Slater R.M., van Ommen G.-J.B., Hagemeijer A., van der Reijden B.A., Breuning M.H. Detection of CBP rearrangements in acute myelogenous leukemia with the t(8;16). Leukemia. 12:1997;2087-2096.
7. Voegel J.J., Heine M.J.S., Zechel C., Chambon P., Gronemeyer H. TIF2, and 160kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15:1996;3667-3675.
8. Spencer T.E., Jenster G., Burcin M.M., Allis C.D., Zhou J., Mizzen C.A., McKenna N.J., Onate S.A., Tsai S.Y., Tsai M.J., O'Malley B.W. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature. 389:1997;194-198.
9. Giles R.H., Peters D.J.M., Breuning M.H. Conjunction dysfunction. CBP/p300 in human disease Trends Genet. 14:1998;178-183.